A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects

A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects

Condition:   Healthy Volunteer
Interventions:   Drug: gilteritinib;   Drug: gilteritinib mini tablet
Sponsor:   Astellas Pharma Global Development, Inc.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 6, 2019Comments OffAssess | Bioavailability | Compared | Dose | Following | Gilteritinib | Healthy | Minitablet | Minitablets | Oral | Relative | Single | Study | Subjects | Suspension | Tablet
Comments